Company Filing History:
Years Active: 2022-2024
Title: Innovations of Hongying Duan Holdsworth in HIV Research
Introduction
Hongying Duan Holdsworth is a notable inventor based in McLean, VA, who has made significant contributions to the field of HIV research. He holds two patents that focus on innovative approaches to immunogens related to HIV-1.
Latest Patents
His latest patents include "Glycan-masked engineered outer domains of HIV-1 gp120 and their use." These patents disclose embodiments of immunogens based on the outer domain of HIV-1 gp120, along with methods of their use and production. The patents also provide nucleic acid molecules encoding the immunogens. In several embodiments, these immunogens can be utilized to prime an immune response to gp120 in a subject, potentially aiding in the treatment or prevention of HIV-1 infection.
Career Highlights
Hongying Duan Holdsworth is affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. His work at this prestigious institution underscores his commitment to advancing medical research and public health.
Collaborations
He collaborates with esteemed colleagues, including Xuejun Chen and Jeffrey C Boyington, to further enhance the impact of his research in the field of immunology.
Conclusion
Hongying Duan Holdsworth's innovative work in developing immunogens for HIV-1 represents a significant advancement in the fight against this virus. His contributions are vital for future research and potential treatments.